[
  {
    "ts": "2025-11-24T13:00:00+00:00",
    "headline": "Iterum Therapeutics Provides Business Update",
    "summary": "DUBLIN, Ireland and CHICAGO, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company” or “Iterum”), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today provided a business update. Recent Events Specialty Distributor Now Stocked: ORLYNVAH™ is now available at McKesson, which will allow certain physicians the ability to procure the product d",
    "url": "https://finance.yahoo.com/news/iterum-therapeutics-provides-business-130000200.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "08460088-f3e8-34b0-b3e1-fb7b7e63bd43",
      "content": {
        "id": "08460088-f3e8-34b0-b3e1-fb7b7e63bd43",
        "contentType": "STORY",
        "title": "Iterum Therapeutics Provides Business Update",
        "description": "",
        "summary": "DUBLIN, Ireland and CHICAGO, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company” or “Iterum”), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today provided a business update. Recent Events Specialty Distributor Now Stocked: ORLYNVAH™ is now available at McKesson, which will allow certain physicians the ability to procure the product d",
        "pubDate": "2025-11-24T13:00:00Z",
        "displayTime": "2025-11-24T13:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/541083ed986d53eadfcc58efb6727c34",
          "originalWidth": 204,
          "originalHeight": 43,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/bOXECb_i54JObPr02CZXJQ--~B/aD00Mzt3PTIwNDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/541083ed986d53eadfcc58efb6727c34.cf.webp",
              "width": 204,
              "height": 43,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pndcETS3f5iegQLzonAgWw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/541083ed986d53eadfcc58efb6727c34.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/iterum-therapeutics-provides-business-130000200.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/iterum-therapeutics-provides-business-130000200.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ITRM"
            },
            {
              "symbol": "MCK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]